According to court documents, Eli Lilly accuses Empower Pharmacy of allegedly selling potentially dangerous versions of its drugs Mounjaro and Zepbound — two injectable medications containing ...

Mumbai: Citing an Aug 2013 legal opinion from the BMC's law department, the Jain temple trust at Vile Parle argued the structure was authenticated and existed prior to 1961- 62, as per the City ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...

A daily pill appears to lower blood sugar in people with type 2 diabetes as effectively as injectable drugs like Ozempic and Mounjaro. The medication, called orforglipron, also led to substantial ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound, generated a combined $5.4 billion in revenue. Zepbound revenue soared from $175.8 million to $1.9 billion, while Mounjaro ...

After a city civil court rejected the Jain temple trust's plea against demolition, the BMC initiated the demolition of a Digambar Jain temple in Vile Parle. The Bombay High Court intervened ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

People who’ve been using more affordable copycat versions of Ozempic or Wegovy to lose weight will no longer have that option. Compounding pharmacies have been allowed to make generic ...

Mumbai: A massive protest in Vile Parle on Saturday as thousands from the Jain community across Mumbai gathered to oppose the proposed demolition of a 90-year-old Digambar Jain temple by the ...